{"disease":{"id":"sialorrhea","name":"sialorrhea"},"drugs":{"marketed":[{"drug_id":"incobotulinumtoxina","indication_name":"Chronic sialorrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xeomin","generic_name":"INCOBOTULINUMTOXINA","company_name":"Merz Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Xeomin works by blocking the release of a chemical messenger called acetylcholine, which signals muscles to contract."},{"drug_id":"rimabotulinumtoxinb","indication_name":"Chronic Sialorrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Myobloc","generic_name":"RIMABOTULINUMTOXINB","company_name":"Elan Pharm","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":53,"revenue":null,"mechanism":"Myobloc works by blocking the release of acetylcholine, a chemical messenger that signals muscles to contract."},{"drug_id":"incobotulinumtoxina","indication_name":"Chronic sialorrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xeomin","generic_name":"INCOBOTULINUMTOXINA","company_name":"Merz Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Xeomin works by blocking the release of a chemical messenger called acetylcholine, which signals muscles to contract."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02270736","title":"Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Merz Pharmaceuticals GmbH","has_results":true},{"nct_id":"NCT04197037","title":"Prevalence of Sialorrhea in Patients Treated With Clozapine","phase":"","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"Parc de Salut Mar","has_results":false},{"nct_id":"NCT04873115","title":"Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties,","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Proveca Pharma Limited","has_results":false},{"nct_id":"NCT07070817","title":"A Clinical Study of Ultrasound-guided Botulinum Toxin A Into Salivary Gland for Sialorrhea After True Bulbar Palsy","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":70,"lead_sponsor_name":"houyajing","has_results":false},{"nct_id":"NCT06101160","title":"Botulinum Toxin Injection for Sialorrhea in Cerebral Palsy","phase":"","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT07516860","title":"Effect of SCS Technique on Oromotor Skills in Children With CP","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT03747536","title":"Ipratropium Bromide Spray as Treatment for Sialorrhea in Children","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"London Health Sciences Centre","has_results":false},{"nct_id":"NCT02613494","title":"Clozapine-induced Hypersalivation - Feasibility Trial","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Mersey Care NHS Trust","has_results":false},{"nct_id":"NCT05164367","title":"Pharmacokinetics of Atropine Oral Gel","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT07067762","title":"Botulinum Toxin Injections Into the Salivary Glands of Cerebrospinal Children With Chronic Sialorrhea","phase":"","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Centre Hospitalier Universitaire de Besancon","has_results":false},{"nct_id":"NCT03704168","title":"Safety and Efficacy of Cryoablation in Management of Sialorrhea in Patients With Neurological Disorders","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Dean Nakamoto","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}